Commerce Bank’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.47M | Buy |
71,268
+3,366
| +5% | +$269K | 0.02% | 375 |
|
|
2025
Q4 | $6.47M | Buy |
67,902
+338
| +0.5% | +$33.1K | 0.04% | 273 |
|
|
2025
Q3 | $6.6M | Buy |
67,564
+2,922
| +5% | +$303K | 0.04% | 277 |
|
|
2025
Q2 | $6.94M | Buy |
64,642
+5,092
| +9% | +$515K | 0.04% | 260 |
|
|
2025
Q1 | $6.01M | Sell |
59,550
-2,046
| -3% | -$206K | 0.04% | 273 |
|
|
2024
Q4 | $5.5M | Sell |
61,596
-395
| -0.6% | -$34.8K | 0.03% | 293 |
|
|
2024
Q3 | $5.19M | Sell |
61,991
-256
| -0.4% | -$20.2K | 0.03% | 307 |
|
|
2024
Q2 | $4.79M | Sell |
62,247
-289
| -0.5% | -$21.2K | 0.03% | 313 |
|
|
2024
Q1 | $4.28M | Sell |
62,536
-221
| -0.4% | -$14.2K | 0.03% | 350 |
|
|
2023
Q4 | $3.63M | Sell |
62,757
-1,240
| -2% | -$66.2K | 0.03% | 365 |
|
|
2023
Q3 | $3.38M | Sell |
63,997
-917
| -1% | -$48.1K | 0.03% | 353 |
|
|
2023
Q2 | $3.51M | Buy |
64,914
+42
| +0.1% | +$2.19K | 0.03% | 353 |
|
|
2023
Q1 | $3.25M | Sell |
64,872
-981
| -1% | -$46.2K | 0.03% | 364 |
|
|
2022
Q4 | $3.05M | Sell |
65,853
-1,832
| -3% | -$79.3K | 0.02% | 374 |
|
|
2022
Q3 | $2.62M | Sell |
67,685
-592
| -0.9% | -$23.7K | 0.02% | 392 |
|
|
2022
Q2 | $2.54M | Sell |
68,277
-12,784
| -16% | -$520K | 0.02% | 409 |
|
|
2022
Q1 | $3.59M | Buy |
81,061
+1,459
| +2% | +$63.2K | 0.02% | 379 |
|
|
2021
Q4 | $3.38M | Buy |
79,602
+901
| +1% | +$37.9K | 0.02% | 396 |
|
|
2021
Q3 | $3.42M | Buy |
78,701
+2,329
| +3% | +$103K | 0.02% | 394 |
|
|
2021
Q2 | $3.27M | Buy |
76,372
+30
| +0% | +$1.26K | 0.02% | 388 |
|
|
2021
Q1 | $2.95M | Sell |
76,342
-13,835
| -15% | -$524K | 0.02% | 387 |
|
|
2020
Q4 | $3.24M | Buy |
90,177
+411
| +0.5% | +$14.8K | 0.03% | 372 |
|
|
2020
Q3 | $3.43M | Sell |
89,766
-7,449
| -8% | -$287K | 0.03% | 330 |
|
|
2020
Q2 | $3.41M | Sell |
97,215
-3,976
| -4% | -$143K | 0.03% | 325 |
|
|
2020
Q1 | $3.3M | Buy |
101,191
+2,252
| +2% | +$88K | 0.04% | 273 |
|
|
2019
Q4 | $4.47M | Buy |
98,939
+6,724
| +7% | +$281K | 0.04% | 249 |
|
|
2019
Q3 | $3.75M | Buy |
92,215
+1,710
| +2% | +$72.4K | 0.04% | 272 |
|
|
2019
Q2 | $3.89M | Buy |
90,505
+1,599
| +2% | +$61.5K | 0.04% | 235 |
|
|
2019
Q1 | $3.41M | Buy |
88,906
+9,924
| +13% | +$379K | 0.04% | 239 |
|
|
2018
Q4 | $2.79M | Buy |
78,982
+4,480
| +6% | +$162K | 0.04% | 244 |
|
|
2018
Q3 | $2.87M | Buy |
74,502
+951
| +1% | +$33.2K | 0.03% | 249 |
|
|
2018
Q2 | $2.4M | Buy |
73,551
+35,012
| +91% | +$1.06M | 0.03% | 272 |
|
|
2018
Q1 | $1.05M | Buy |
38,539
+1,009
| +3% | +$27.4K | 0.01% | 399 |
|
|
2017
Q4 | $931K | Sell |
37,530
-722
| -2% | -$19.9K | 0.01% | 419 |
|
|
2017
Q3 | $1.12M | Buy |
38,252
+28,449
| +290% | +$786K | 0.02% | 388 |
|
|
2017
Q2 | $272K | Buy |
9,803
+1,471
| +18% | +$39K | ﹤0.01% | 708 |
|
|
2017
Q1 | $207K | Buy |
+8,332
| New | +$203K | ﹤0.01% | 769 |
|
Other funds holding BSX
VCM
VPM
Commerce Bank's BSX Position: Q1 2026 in Review
Commerce Bank increased its Boston Scientific (BSX) stake by 5% in Q1 2026, buying an estimated $269K and bringing the position to 71,268 shares worth $4.47M. The position accounts for 0.02% of the portfolio, ranked #375.
Commerce Bank first reported a position in BSX in Q1 2017 and has held it in 37 quarters since. The position peaked at $6.94M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Commerce Bank held 71,268 shares of Boston Scientific worth $4.47M as of Q1 2026.
- Commerce Bank bought 3,366 Boston Scientific shares in Q1 2026, an estimated $269K.
- Boston Scientific made up 0.02% of Commerce Bank's portfolio in Q1 2026, its #375 holding.
- Commerce Bank first reported a position in Boston Scientific in Q1 2017 and has held it in 37 quarters since.
- Commerce Bank's Boston Scientific position peaked at $6.94M in Q2 2025.
- 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Commerce Bank's 13F filing for Q1 2026, filed 11 May 2026.